A new mathematical model approach on the oncolytic virotherapy potency
Authors
A. T. Alshammari
- Department of Mathematical Sciences, Faculty of Science, Universiti Teknologi Malaysia, Johor Bahru 81310, Johor, Malaysia.
- Department of Mathematics, Faculty of Science, University of Hafr Al Batin, Hafr Al Batin, Saudi Arabia.
N. Maan
- Department of Mathematical Sciences, Faculty of Science, Universiti Teknologi Malaysia, Johor Bahru 81310, Johor, Malaysia.
M. A. M. Abdelaziz
- School of Quantitative Sciences, College of Arts \(\&\) Sciences, Universiti Utara Malaysia, Kedah, Malaysia.
- Department of Mathematics, Faculty of Arts and Sciences, Najran University, Najran, Saudi Arabia.
Abstract
In recent times, there has been an increasing focus on investigating the therapeutic capacity of virus particles in the management of cancer. This paper introduces a novel discrete-time mathematical model with fractional-order of oncolytic virotherapy. The model captures the complex behavior of how cancer cells and virus particles interact, aiming to elucidate the process of infecting and eliminating cancer cells in the absence of immune involvement. To evaluate the efficacy of cancer-targeting virus treatment, we perform an in-depth analysis of both the local stability and the bifurcation trends observed in our framework. By selecting appropriate bifurcation parameters, we verify the occurrence of codimension one bifurcations, for instance, fold, flip as well as Neimark-Sacker (N-S), as well as codimension-two flip-N-S bifurcations.
The identification of these bifurcation types is established by deriving necessary and sufficient conditions using algebraic criterion methods. In these criteria, the reliance does not lie in the attributes of the eigenvalue coefficients from the characteristic equation of the Jacobian matrix but rather on the coefficients of the Jacobian matrix's characteristic equation itself. Consequently, we have semi-algebraic systems comprising equations, inequalities, and inequalities. This algebraic methodology provides appropriate conditions for both codimension one as well as codimension-two bifurcations in high-dimensional maps. Finally, numerical simulations were conducted to validate our theoretical findings. Our study concludes that the correlated increase between cancer cell proliferation and the therapeutic virus indeed resulted in the anticipated infection within the cancer cells. While complete eradication of cancer cells using viral therapy alone is not impossible, it requires specific conditions.
Share and Cite
ISRP Style
A. T. Alshammari, N. Maan, M. A. M. Abdelaziz, A new mathematical model approach on the oncolytic virotherapy potency, Journal of Mathematics and Computer Science, 36 (2025), no. 1, 99--120
AMA Style
Alshammari A. T. , Maan N. , Abdelaziz M. A. M. , A new mathematical model approach on the oncolytic virotherapy potency. J Math Comput SCI-JM. (2025); 36(1):99--120
Chicago/Turabian Style
Alshammari, A. T. , Maan, N. , Abdelaziz, M. A. M. . "A new mathematical model approach on the oncolytic virotherapy potency." Journal of Mathematics and Computer Science, 36, no. 1 (2025): 99--120
Keywords
- Virotherapy cancer treatment
- calculus involving fractional orders
- model in discrete time
- equilibrium stability
- bifurcations
- chaos
MSC
References
-
[1]
M. A. M. Abdelaziz, A. I. Ismail, F. A. Abdullah, M. H. Mohd, Bifurcations and chaos in a discrete SI epidemic model with fractional order, Adv. Difference Equ., 2018 (2018), 1–19
-
[2]
M. A. M. Abdelaziz, A. I. Ismail, F. A. Abdullah, M. H. Mohd, Codimension one and two bifurcations of a discrete-time fractional-order SEIR measles epidemic model with constant vaccination, Chaos Solitons Fractals, 140 (2020), 14 pages
-
[3]
M. J. Ailia, S. Y. Yoo, In vivo oncolytic virotherapy in murine models of hepatocellular carcinoma: a systematic review, Vaccines, 10 (2022), 1–16
-
[4]
A. H. Alblowy, N. Maan, S. A. Alharbi, Role of glucose risk factors on human breast cancer: A nonlinear dynamical model evaluation, Mathematics, 10 (2022), 1–20
-
[5]
A. A. Al-Zaher, R. Moreno, C. A. Fajardo, M. Arias-Badia, M. Farrera, J. de Sostoa, L. A. Rojas, R. Alemany, Evidence of anti-tumoral efficacy in an immune competent setting with an irgd-modified hyaluronidase-armed oncolytic adenovirus, Mol. Ther., 8 (2018), 62–70
-
[6]
S. E. Berkey, S. H. Thorne, D. L. Bartlett, Oncolytic virotherapy and the tumor microenvironment, In: Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy, Adv. Exp. Med. Biol., Springer, Cham, (2017), 157–172
-
[7]
H. Boutayeb, S. Bidah, O. Zakary, M. Rachik, A new simple epidemic discrete-time model describing the dissemination of information with optimal control strategy, Discrete Dyn. Nat. Soc., 2020 (2020), 11 pages
-
[8]
W. M. Chan, G. McFadden, Oncolytic poxviruses, Annu. Rev. Virol., 1 (2014), 191–214
-
[9]
B. S. Chhikara, K. Parang, Global cancer statistics 2022: the trends projection analysis, Chem. Biol. Lett., 10 (2023), 1–16
-
[10]
A. El-Sayed, S. Salman, On a discretization process of fractional-order riccati differential equation, J. Fract. Calc. Appl., 4 (2013), 251–259
-
[11]
M. Farman, A. Akg¨ ul, A. Ahmad, S. Imtiaz, Analysis and dynamical behavior of fractional-order cancer model with vaccine strategy, Math. Methods Appl. Sci., 43 (2020), 4871–4882
-
[12]
A. C. Filley, M. Dey, Immune system, friend or foe of oncolytic virotherapy?, Front. Oncol., 7 (2017), 1–17
-
[13]
A. L. Jenner, A. C. F. Coster, P. S. Kim, Treating cancerous cells with viruses: insights from aminimal model for oncolytic virotherapy, Lett. Biomath., 5 (2018), S117–S136
-
[14]
P. Kumar, V. S. Erturk, A. Yusuf, S. Kumar, Fractional time-delay mathematical modeling of oncolytic virotherapy, Chaos Solitons Fractals, 150 (2021), 14 pages
-
[15]
X. Li, C. Mou, W. Niu, D.Wang, Stability analysis for discrete biological models using algebraic methods, Math. Comput. Sci., 5 (2011), 247–262
-
[16]
A. C. J. Luo, Regularity and complexity in dynamical systems, Springer, New York (2012)
-
[17]
A. M. Malfitano, S. Di Somma, N. Prevete, G. Portella, Virotherapy as a potential therapeutic approach for the treatment of aggressive thyroid cancer, Cancers, 11 (2019), 1–21
-
[18]
J. Malinzi, A mathematical model for oncolytic virus spread using the telegraph equation, Commun. Nonlinear Sci. Numer. Simul., 102 (2021), 16 pages
-
[19]
C. E. Miller, The endometrioma treatment paradigm when fertility is desired: a systematic review, J. Minim. Invasive Gynecol., 28 (2021), 575–586
-
[20]
K. D. Miller, L. Nogueira, A. B. Mariotto, J. H. Rowland, K. R. Yabroff, C. M. Alfano, A. Jemal, J. L. Kramer, R. L. Siegel, Cancer treatment and survivorship statistics, 2019, CA Cancer J. Clin., 69 (2019), 363–685
-
[21]
H. Murphy, H. Jaafari, H. M. Dobrovolny, Differences in predictions of ode models of tumor growth: a cautionary example, BMC Cancer, 16 (2016), 1–10
-
[22]
W. Niu, J. Shi, C. Mou, Analysis of codimension 2 bifurcations for high-dimensional discrete systems using symbolic computation methods, Appl. Math. Comput., 273 (2016), 934–947
-
[23]
E. Ratajczyk, U. Ledzewicz, H. Sch¨attler, Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF- inhibitors, J. Optim. Theory Appl., 176 (2018), 456–477
-
[24]
L. A. Santry, J. P. van Vloten, J. P. Knapp, K. Matuszewska, T. M. McAusland, J. A. Minott, R. C. Mould, A. A. Stegelmeier, P. P. Major, S. K. Wootton, J. J. Petrik, B. W. Bridle, Tumour vasculature: friend or foe of oncolytic viruses?, Cytokine Growth Factor. Rev., 56 (2020), 69–82
-
[25]
E. Shirbhate, R. Veerasamy, S. H. S. Boddu, A. K. Tiwari, H. Rajak, Histone deacetylase inhibitor-based oncolytic virotherapy: A promising strategy for cancer treatment, Drug Discov. Today, 27 (2022), 1689–1697
-
[26]
J. d. Sostoa, V. Dutoit, D. Migliorini, Oncolytic viruses as a platform for the treatment of malignant brain tumors, Int. J. Mol. Sci., 21 (2020), 1–21
-
[27]
Y. R. Suryawanshi, A. J. Schulze, Oncolytic viruses for malignant glioma: on the verge of success?, Viruses, 13 (2021), 1–25
-
[28]
C. A. Valentim, J. A. Rabi, S. A. David, Fractional mathematical oncology: On the potential of non-integer order calculus applied to interdisciplinary models, Biosystems, 204 (2021),
-
[29]
C. A. Valentim Jr, N. A. Oliveira, J. A. Rabi, S. A. David, Can fractional calculus help improve tumor growth models?, J. Comput. Appl. Math., 379 (2020), 15 pages
-
[30]
P. Van den Driessche, J. Watmough, Further notes on the basic reproduction number, Springer, Berlin, 1945 (2008), 159–178
-
[31]
B. D. Weinberg, J. Gao, Polymer implants for intratumoral drug delivery and cancer therapy, CRC Press, (2020)
-
[32]
G. Wen, Criterion to identify Hopf bifurcations in maps of arbitrary dimension, Phys. Rev. E (3), 72 (2005), 4 pages
-
[33]
G. Wen, S. Chen, Q. Jin, A new criterion of period-doubling bifurcation in maps and its application to an inertial impact shaker, J. Sound Vib., 311 (2008), 212–223
-
[34]
D. Wodarz, Gene therapy for killing p53-negative cancer cells: use of replicating versus nonreplicating agents, Hum. Gene Ther., 14 (2003), 153–159
-
[35]
T. Yamada, Y. Hamano, N. Hasegawa, E. Seo, K. Fukuda, K. K Yokoyama, I. Hyodo, M. Abei, Oncolytic virotherapy and gene therapy strategies for hepatobiliary cancers, Curr. Cancer Drug Targets, 18 (2008), 188–201
-
[36]
S. Yao, New bifurcation critical criterion of flip-Neimark-Sacker bifurcations for two-parameterized family of n-dimensional discrete systems, Discrete Dyn. Nat. Soc., 2012 (2012), 12 pages
-
[37]
Y. Zhou, J. W. He, A cauchy problem for fractional evolution equations with hilfer’s fractional derivative on semiinfinite interval, Fract. Calc. Appl. Anal., 25 (2022), 924–961